Hypertrophic Cardiomyopathy Management
What is it?
Hypertrophic cardiomyopathy is a genetic disorder in which the heart muscle thickens abnormally. This primarily occurs in the wall (septum) that divides the two lower chambers of the heart (ventricles). Blood flow in and out of the heart is blocked as a result and decreases the heart's ability to function. Patients with hypertrophic cardiomyopathy are at risk of heart failure, heart rhythm disorders, or sudden death.
Several diagnostic tools may be used to evaluate hypertrophic cardiomyopathy, including cardiac catheterization techniques and advanced cardiovascular imaging techniques. The condition has varying treatments, including medical management, ablation, device implantation, or cardiac surgery. Hypertrophic cardiomyopathy is genetic. Our physicians may suggest that family members be tested to determine their risk of acquiring the condition.
The Loyola difference
Because Loyola is a leading academic medical center with access to advanced technology and clinical trials, its cardiomyopathy and heart failure patients often benefit from life-saving techniques and procedures that may not be available elsewhere. Our multidisciplinary team of cardiologists, cardiovascular surgeons, genetic counselors and other specialists have significant expertise in evaluation, diagnosis and treatment of this condition.
Loyola is a nationally recognized leader in cardiac care. U.S. News & World Report ranked us as a top 20 hospital for cardiology and heart surgery in 2011, making this our ninth year in the top 50.